Health

  • November 10, 2025

    Kochava, Class Seek Final OK For Location Data Settlement

    Mobile device users have come to terms with data analytics provider Kochava to end their claims that the company had been selling their geolocation data without proper consent after nearly three years of litigation.

  • November 10, 2025

    No Excuse For No Doctor's Note In Med Mal Suit, NJ Court Says

    A New Jersey appeals court on Monday affirmed the dismissal of a medical malpractice suit against a hospital and two doctors, saying there were no extraordinary circumstances to warrant allowing the suit to proceed without the mandatory affidavit of merit from a doctor supporting the claims.

  • November 10, 2025

    Fired Cancer Center Worker's ADA Suit Kicked To Pa. Court

    A New Jersey federal judge ruled Monday that a disability bias suit brought by a former worker for the Philadelphia-based Fox Chase Cancer Center belongs in Pennsylvania federal court because her New Jersey-based remote work arrangement wasn't enough to tether the case to the Garden State. 

  • November 10, 2025

    Accolade Wants 'Slip Of The Tongue' Investor Fraud Suit Axed

    Accolade Inc. and its CEO have asked a New York federal judge to toss a suit alleging they made false statements about the healthcare company's profitability to prop up share prices before announcing plans to go private, saying the amended complaint is investors' "second attempt to plead a 'fraud' case based on an obvious slip of the tongue."

  • November 10, 2025

    Pfizer Again Asks Judge To Toss States' Price-Fixing Case

    Pfizer has again asked a Connecticut federal judge to throw out claims it faces in a sprawling dermatology drug price-fixing lawsuit filed by multiple states against several pharmaceutical companies, arguing allegations against it were "scant and cursory."

  • November 10, 2025

    Acadia Healthcare Inks Investor Settlement Days Before Trial

    Acadia Healthcare Co. Inc. and plaintiffs in a securities class action accusing the company of misleading investors about the strength of its United Kingdom operations have reached a settlement in principle, avoiding a trial that was set for later this month.

  • November 10, 2025

    Humana Sues ChenMed In Del. Over 'Imposed' License Fees

    Humana Inc. sued ChenMed LLC on Monday in Delaware's Court of Chancery, accusing the multistate senior healthcare network and its affiliates of imposing unauthorized technology license fees and other charges to siphon "tens of millions" in revenues from the insurance giant through the companies' JenCare joint venture.

  • November 10, 2025

    Pot Shop Bombards People With Promo Texts, TCPA Suit Says

    A Southern California cannabis dispensary was hit with a proposed class action in federal court Friday alleging it violated the Telephone Consumer Protection Act by sending unsolicited telemarketing messages to individuals to promote its services, despite the fact their numbers have been placed on the national Do Not Call registry.

  • November 10, 2025

    FDA Lifts Hormone Replacement 'Black Box' Warnings

    The U.S. Food and Drug Administration on Monday said it was removing the "black box" warnings from hormone replacement therapy treatments for menopause for the risks of cardiovascular disease, breast cancer and probable dementia.

  • November 10, 2025

    Medicaid Scammer Wants Habba Off $100M Kickback Case

    A Florida man who was convicted of participating in a Medicaid fraud scheme and was prosecuted in New Jersey has requested that a federal judge disqualify acting U.S. Attorney Alina Habba from the case, saying she has been illegally supervising prosecutors assigned to the matter.

  • November 10, 2025

    Gov't Can Support Anti-Abortion Group In NJ Subpoena Fight

    The U.S. Supreme Court on Monday granted Solicitor General D. John Sauer's request to file an amicus brief and participate in oral argument in an anti-abortion pregnancy center's bid to revive its challenge to a subpoena from the New Jersey attorney general demanding information about its donors.

  • November 10, 2025

    FTC Risks Help Push Metsera Back To Pfizer

    Novo Nordisk AS' aspirations to pry Metsera away from Pfizer Inc. collapsed over the weekend under the pressure of a revised Pfizer offer, twin court challenges and "a call from the U.S. Federal Trade Commission."

  • November 10, 2025

    Mich. Justices To Hear If Signed Form Shields Hospital

    The Michigan Supreme Court has agreed to hear arguments on whether a patient's signed consent form alone is enough to defeat a medical malpractice suit claiming a Michigan hospital was responsible for an independent contractor physician's alleged negligence.

  • November 10, 2025

    High Court Won't Review Vax Refuser's Loss In ADA Suit

    The U.S. Supreme Court declined on Monday to hear a former Johns Hopkins University lab engineer's challenge to her loss in a disability discrimination suit alleging she was fired for refusing to get the COVID-19 vaccine because of an immunity condition related to Lyme disease.

  • November 10, 2025

    Justices Turn Away United, Disney Workers' COVID Vax Fights

    The U.S. Supreme Court on Monday rejected separate appeals by workers at United Airlines and The Walt Disney Co. that accused each company of unlawfully denying exemptions to COVID-19 vaccination policies.

  • November 07, 2025

    4th Circ. Opioid Case Brings Public Nuisance Back To The Fore

    The Fourth Circuit's ruling that upturned a lower court win for drug distributors in a battle with the West Virginia county at the epicenter of the opioid epidemic was a blast from the past from the fever pitch of courtroom battles over the national crisis just a few years ago.

  • November 07, 2025

    Sleep Apnea Device Co. Investor Says Rollout Was Botched

    Medical device company Inspire Medical Systems has been hit with a proposed investor class action alleging its shares dropped by nearly a third of their value after the public learned it concealed low demand and rollout shortcomings associated with its newest sleep apnea device.

  • November 07, 2025

    Spurned Pfizer Turns To Antitrust Law To Reclaim Biotech

    What may be a first-of-its-kind lawsuit is playing out as Pfizer Inc. turns to antitrust law to keep Novo Nordisk from usurping its bid for Metsera.

  • November 07, 2025

    Fla. Hospital Blamed For Child Bone Marrow Transplant Death

    The parents of a child who died following a bone marrow transplant have sued Nicklaus Children's Hospital for alleged negligence, saying in a Florida complaint that doctors performed an unnecessary, risky procedure without their consent. 

  • November 07, 2025

    Seattle Pot Shop Slapped With Site Tracking Pixel Privacy Suit

    A Seattle cannabis dispensary has been hit with a proposed class action in Washington federal court by a customer who claims the retailer shared his private information about medical marijuana appointments and pot purchases with Google and other third parties by using online browser tracking tools on its website.

  • November 07, 2025

    Mich. County Not Liable For Officers' Age Bias, Judge Says

    A Michigan federal judge has tossed a registered nurse's suit alleging Berrien County discriminated against her because of her age, finding that although the nurse showed she was harassed by jail officers because of her age, she didn't demonstrate that the county was responsible for it.

  • November 07, 2025

    8th Circ. Upholds EpiPen Co. Worker's Reinstatement

    The Eighth Circuit affirmed an arbitration award ordering EpiPen maker Meridian Medical to reinstate an employee accused of falsifying job training records, ruling Friday the decision doesn't violate public policy since there are no federal regulations governing auto-injector training that forbids reinstatement for a procedural training violation. 

  • November 07, 2025

    How One Law Firm Got Two Big White-Collar Wins In 48 Hours

    The white-collar team at Dykema Gossett PLLC secured back-to-back dismissals of two criminal cases in as many days last month by challenging the government's experts, flagging discovery issues and hammering on other perceived weaknesses in the prosecutions.

  • November 07, 2025

    Jury Clears Novo Nordisk Of Medicaid Fraud Over Blood Drug

    A Tacoma federal jury cleared Novo Nordisk on Friday of allegations that it defrauded Washington state's Medicaid and Medicare systems by paying kickbacks and promoting off-label use to illegally boost prescriptions of its hemophilia drug NovoSeven.

  • November 07, 2025

    Fla. Judge Sentences HIV Drug Fraudster To 8 Years In Prison

    A Florida federal judge on Friday sentenced a man to more than eight years in prison after he pled guilty to a wire fraud-related charge in connection to a roughly $100 million HIV medication fraud scheme, referencing the harm that called into question the nation's pharmaceutical drug supply. 

Expert Analysis

  • Budget Act Should Boost Focus On Trade Compliance

    Author Photo

    Passage of the One Big Beautiful Budget Act, coupled with recent U.S. Department of Justice statements that it will use the False Claims Act aggressively to pursue trade, tariff and customs fraud, marks a sharp increase in trade-related enforcement risk, say attorneys at Debevoise.

  • Associates Can Earn Credibility By Investing In Relationships

    Author Photo

    As the class of 2025 prepares to join law firms this fall, new associates must adapt to office dynamics and establish credible reputations — which require quiet, consistent relationship-building skills as much as legal acumen, says Kyle Forges at Bast Amron.

  • New Colo. Teen Privacy Rules Signal National Regulatory Shift

    Author Photo

    Recently released proposed rule amendments to the Colorado Privacy Act that would create some of the most robust protections for minors' online data in the U.S. reflect an ongoing trend of states taking steps to extend privacy protection for their residents, complicating the compliance burden for companies, say attorneys at Morgan Lewis.

  • A Shifting Trend In FDA Form 483 Disclosure Obligations

    Author Photo

    A New York federal court's Checkpoint Therapeutics decision extends a recent streak of dismissals of securities class actions alleging that pharmaceutical companies failed to disclose U.S. Food and Drug Administration Form 483 inspection reports, providing critical guidance for companies during the FDA approval process, say attorneys at Alston & Bird.

  • Lessons From 7th Circ.'s Deleted Chat Sanctions Ruling

    Author Photo

    The Seventh Circuit’s recent decision in Pable v. Chicago Transit Authority, affirming the dismissal of an ex-employee’s retaliation claims, highlights the importance of properly handling the preservation of ephemeral messages and clarifies key sanctions issues, says Philip Favro at Favro Law.

  • Mitigating Employer Liability Risk Under Sex Assault Rule

    Author Photo

    The American Law Institute's newly approved rule expands vicarious liability to employers for certain sexual assaults that employees commit, which could materially increase employers' exposure unless they strengthen safeguards around high-risk roles, say attorneys at Morgan Lewis.

  • Breaking Down The Proposed Hemp Bill

    Author Photo

    A proposed bill in the U.S. House of Representatives, recently approved by the House Appropriations Committee, contains a rider that would significantly change the definition of hemp and dramatically reshape the current hemp-derived product market, say attorneys at King & Spalding.

  • Series

    Quilting Makes Me A Better Lawyer

    Author Photo

    Turning intricate patterns of fabric and thread into quilts has taught me that craftsmanship, creative problem-solving and dedication to incremental progress are essential to creating something lasting that will help another person — just like in law, says Veronica McMillan at Kramon & Graham.

  • Lessons Learned 3 Years After First CCPA Enforcement Action

    Author Photo

    Three years after the first public enforcement action under the California Consumer Privacy Act, Attorney General Rob Bonta has pursued a steady stream of enforcement actions across industries, providing a clearer picture of how the law is being interpreted and enforced, says Tatum Andres at Kilpatrick.

  • How To Prep For Potential Passage Of SAFER Banking Act

    Author Photo

    The Secure and Fair Enforcement Regulation, or SAFER, Banking Act, could fundamentally reshape how financial institutions interact with cannabis businesses, so operators that move now to get their house in order will be best positioned to capitalize if and when change comes, says Alex Leonowicz at Howard & Howard.

  • The Future Of Lab-Test Regs After FDA Rescinds Rule

    Author Photo

    The U.S. Food and Drug Administration recently rescinded its laboratory-developed tests rule in response to a Texas federal court decision this spring, reinforcing a separation of authority between the FDA and the Centers for Medicare & Medicaid Services, and calling into question the FDA's role in overseeing such tests without congressional action, say attorneys at Venable.

  • What 2 Profs Noticed As Transactional Law Students Used AI

    Author Photo

    After a semester using generative artificial intelligence tools with students in an entrepreneurship law clinic, we came away with numerous observations about the opportunities and challenges such tools present to new transactional lawyers, say professors at Cornell Law School.

  • Rebuttal

    BigLaw Settlements Should Not Spur Ethics Deregulation

    Author Photo

    A recent Law360 op-ed argued that loosening law firm funding restrictions would make BigLaw firms less inclined to settle with the Trump administration, but deregulating legal financing ethics may well prove to be not merely ineffective, but counterproductive, says Laurel Kilgour at the American Economic Liberties Project.

  • Opinion

    8th Circ. Should Reaffirm False Commercial Speech's Nature

    Author Photo

    The Eighth Circuit in Goldfinch Laboratory v. Iowa Pathology Associates should assert that false commercial speech is not categorically immune from antitrust scrutiny, says Daniel Graulich at the Federal Trade Commission.

  • Unpacking Ore. Law's Limits On PE Healthcare Investment

    Author Photo

    A recent Oregon law imposes significant restrictions on nonphysicians owning or controlling medical practices, but newly enacted amendments provide some additional flexibility in certain ownership arrangements without scuttling the law's intent of addressing concerns about the rise of private equity investment in healthcare, say attorneys at Debevoise.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Health archive.